take phenylpropanolamine off the market

The FDA's decision to take phenylpropanolamine off the market is causing quite a stir.

Patients are asking for alternates now that PPA is associated with a risk of hemorrhagic stroke...especially in young women.

There are plenty of allergy and cold meds that use different decongestants than phenylpropanolamine (PPA).

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote